Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2026-01-03 @ 7:25 AM
Study NCT ID:
NCT01185366
Status:
TERMINATED
Last Update Posted:
2021-04-28
First Post:
2010-08-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Kidney Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Advanced non-clear cell renal cell cancer (RCC) | View |
| None | Clear-cell renal cell carcinoma | View |
| None | Collecting duct carcinoma | View |
| None | Translocation carcinoma | View |
| None | Chromophobe | View |
| None | Everolimus | View |
| None | Sunitinib | View |
| None | Afinitor | View |
| None | RAD001 | View |
| None | Sunitinib Malate | View |
| None | SUO11248 | View |
| None | Sutent | View |
| None | ESPN | View |